| Date Filed | Type | Description |
| 06/29/2023 |
4
| Leach Jacob Steven (Director) has filed a Form 4 on SenesTech, Inc.|
Txns:
| Granted 41,010 options to buy
@ $1.25, valued at
$51.3k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/14/2023 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Disposed/sold 3,540 shares
@ $111.399, valued at
$394.4k
Disposed/sold 7,986 shares
@ $111.399, valued at
$889.6k
Disposed/sold 4,583 shares
@ $111.399, valued at
$510.5k
|
|
| 03/10/2023 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 25,397 shares
@ $0.001, valued at
$25.4 |
|
| 03/06/2023 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 10,425 shares
@ $114.4476, valued at
$1.2M
Sold 7,719 shares
@ $115.1323, valued at
$888.7k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 6,741 shares
@ $0.001, valued at
$6.7
Disposed/sold 1,317 shares
@ $406.0567, valued at
$534.8k
Disposed/sold 2,065 shares
@ $406.0567, valued at
$838.5k
Disposed/sold 891 shares
@ $406.0567, valued at
$361.8k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 12,087 shares
@ $476.7, valued at
$5.8M
|
|
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| Leach Jacob Steven (Director) has filed a Form 4 on SenesTech, Inc.|
Txns:
| Granted 27,046 options to buy
@ $1.41, valued at
$38.1k
|
|
| 11/24/2020 |
3
| Leach Jacob Steven (Director) has filed a Form 3 on SenesTech, Inc. |
| 09/11/2020 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 2,577 shares
@ $398.302, valued at
$1M
Sold 1,283 shares
@ $398.302, valued at
$511k
|
|
| 06/15/2020 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 1,700 shares
@ $372.9693, valued at
$634k
Sold 2,600 shares
@ $374.2958, valued at
$973.2k
Sold 1,800 shares
@ $375.6823, valued at
$676.2k
Sold 3,481 shares
@ $376.7763, valued at
$1.3M
Sold 7,466 shares
@ $377.9823, valued at
$2.8M
Sold 1,982 shares
@ $379.4167, valued at
$752k
Sold 100 shares
@ $380.055, valued at
$38k
|
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2019 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 4,499 shares
@ $145.1949, valued at
$653.2k
Sold 600 shares
@ $146.2933, valued at
$87.8k
|
|
| 04/25/2019 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Exercised 4,797 options to buy
@ $7.27, valued at
$34.9k
|
|
| 03/13/2019 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 5,001 shares
@ $142.7922, valued at
$714.1k
Sold 1,878 shares
@ $142.7922, valued at
$268.2k
Sold 1,676 shares
@ $142.7922, valued at
$239.3k
|
|
| 03/11/2019 |
4
| Leach Jacob Steven (EVP Chief Technology Officer) has filed a Form 4 on DEXCOM INC|
Txns:
| Granted 14,987 shares
@ $0.001, valued at
$15 |
|
| 10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2018 |
4
| Leach Jacob Steven (SVP, Research & Development) has filed a Form 4 on DEXCOM INC|
Txns:
| Exercised 15,000 options to buy
@ $5.92, valued at
$88.8k
|
|
| 09/12/2018 |
4
| Leach Jacob Steven (SVP, Research & Development) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 1,936 shares
@ $143.7552, valued at
$278.3k
Sold 2,678 shares
@ $143.7552, valued at
$385k
|
|
| 08/28/2018 |
4
| Leach Jacob Steven (SVP, Research & Development) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 10,577 shares
@ $138.3173, valued at
$1.5M
Sold 10,000 shares
@ $138.3173, valued at
$1.4M
Exercised 10,577 options to buy
@ $3.19, valued at
$33.7k
Exercised 10,000 options to buy
@ $5.92, valued at
$59.2k
|
|
| 05/17/2018 |
4
| Leach Jacob Steven (SVP, Research & Development) has filed a Form 4 on DEXCOM INC|
Txns:
| Gifted 176 shares
@ $0 |
|
| 05/10/2018 |
4
| Leach Jacob Steven (SVP, Research & Development) has filed a Form 4 on DEXCOM INC|
Txns:
| Sold 1,923 shares
@ $84.9536, valued at
$163.4k
Sold 8,542 shares
@ $84.7716, valued at
$724.1k
Sold 203 shares
@ $84.7716, valued at
$17.2k
Sold 2,500 shares
@ $85.1495, valued at
$212.9k
Exercised 1,923 options to buy
@ $3.19, valued at
$6.1k
Exercised 203 options to buy
@ $7.27, valued at
$1.5k
Exercised 8,542 options to buy
@ $9.78, valued at
$83.5k
|
|
|